Review Article| Volume 2, ISSUE 1, P13-24, May 2022

Breast Cancer-Related Lymphedema

Causes, Detection, Prevention, and Treatment
Published:April 07, 2022DOI:
      Lymphatic fluid is composed of water, protein, and other debris emited from capillary beds into the intersitium


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Advances in Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kataru R.P.
        • Wiser I.
        • Baik J.E.
        • et al.
        Fibrosis and secondary lymphedema: chicken or egg?.
        Transl Res. 2019; 209: 68-76
        • Bui K.
        • Hong Y.K.
        Ras pathways on Prox1 and Lymphangiogenesis: insights for therapeutics.
        Front Cardiovasc Med. 2020; 7: 597374
        • García Nores G.D.
        • Ly C.L.
        • Savetsky I.L.
        • et al.
        Regulatory T Cells mediate local immunosuppression in lymphedema.
        J Invest Dermatol. 2018; 138: 325-335
        • Foldi M.
        • Foldi E.
        • Strobenreuther R.
        • R Strobenreuther
        Földi’s Textbook of Lymphology.
        3rd edition. Mosby, 2012
        • Kelly D.G.
        A primer on lymphedema.
        1st edition. Prentice Hall, Hoboken, New Jersey2004
        • Bálint L.
        • Jakus Z.
        Mechanosensation and Mechanotransduction by Lymphatic endothelial cells act as important regulators of lymphatic development and function.
        Int J Mol Sci. 2021; 22: 3955
        • Bergan B.-B.L.G.R.
        Lymphedema, A concise compendium of theory and practice.
        Springer-Verlag, Berlin/Heidelberg, Germany2011
        • Yoshida S.
        • Koshima I.
        • Hamada Y.
        • et al.
        Lymphovenous anastomosis aids wound healing in lymphedema: relationship between lymphedema and delayed wound healing from a view of immune mechanisms.
        Adv Wound Care (New Rochelle). 2019; 8: 263-269
        • Azhar S.H.
        • Lim H.Y.
        • Tan B.K.
        • et al.
        The unresolved pathophysiology of lymphedema.
        Front Physiol. 2020; 11: 137
        • Yuan Y.
        • Arcucci V.
        • Levy S.M.
        • et al.
        Modulation of immunity by lymphatic dysfunction in lymphedema.
        Front Immunol. 2019; 10: 76
        • Carlson J.A.
        Lymphedema and subclinical lymphostasis (microlymphedema) facilitate cutaneous infection, inflammatory dermatoses, and neoplasia: a locus minoris resistentiae.
        Clin Dermatol. 2014; 32: 599-615
        • Ferguson C.M.
        • Swaroop M.N.
        • Horick N.
        • et al.
        Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer.
        J Clin Oncol. 2016; 34: 691-698
        • Bromham N.
        • Schmidt-Hansen M.
        • Astin M.
        • et al.
        Axillary treatment for operable primary breast cancer.
        Cochrane Database Syst Rev. 2017; 1: Cd004561
        • Giuliano A.E.
        • Hunt K.K.
        • Ballman K.V.
        • et al.
        Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
        JAMA. 2011; 305: 569-575
        • Jagsi R.
        • Chadha M.
        • Moni J.
        • et al.
        Radiation field design in the ACOSOG Z0011 (Alliance) Trial.
        J Clin Oncol. 2014; 32: 3600-3606
        • Galimberti V.
        • Cole B.F.
        • Zurrida S.
        • et al.
        Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
        Lancet Oncol. 2013; 14: 297-305
        • Donker M.
        • van Tienhoven G.
        • Straver M.E.
        • et al.
        Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
        Lancet Oncol. 2014; 15: 1303-1310
        • Shaitelman S.F.
        • Chiang Y.J.
        • Griffin K.D.
        • et al.
        Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis.
        Breast Cancer Res Treat. 2017; 162: 201-215
        • Whelan T.J.
        • Olivotto I.A.
        • Parulekar W.R.
        • et al.
        Regional nodal irradiation in early-stage breast cancer.
        N Engl J Med. 2015; 373: 307-316
        • Warren L.E.
        • Miller C.L.
        • Horick N.
        • et al.
        The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study.
        Int J Radiat Oncol Biol Phys. 2014; 88: 565-571
        • Hayes S.B.
        • Freedman G.M.
        • Li T.
        • et al.
        Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation?.
        Int J Radiat Oncol Biol Phys. 2008; 72: 1449-1455
        • Naoum G.E.
        • Roberts S.
        • Brunelle C.L.
        • et al.
        Quantifying the impact of axillary surgery and nodal irradiation on breast cancer–related lymphedema and local tumor control: long-term results from a prospective screening trial.
        J Clin Oncol. 2020; 38: 3430-3438
        • Poortmans P.M.
        • Collette S.
        • Kirkove C.
        • et al.
        Internal mammary and medial supraclavicular irradiation in breast cancer.
        New Engl J Med. 2015; 373: 317-327
        • Gross J.P.
        • Sachdev S.
        • Helenowski I.B.
        • et al.
        Radiation therapy field design and lymphedema risk after regional nodal irradiation for breast cancer.
        Int J Radiat Oncol Biol Phys. 2018; 102: 71-78
        • Gross J.P.
        • Lynch C.M.
        • Flores A.M.
        • et al.
        Determining the organ at risk for lymphedema after regional nodal irradiation in breast cancer.
        Int J Radiat Oncol Biol Phys. 2019; 105: 649-658
        • Holman F.A.
        • Bosman S.J.
        • Haddock M.G.
        • et al.
        Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres.
        Eur J Surg Oncol. 2017; 43: 107-117
        • Sun F.
        • Skolny M.N.
        • Swaroop M.N.
        • et al.
        The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema.
        Breast Cancer Res Treat. 2016; 157: 229-240
        • Ancukiewicz M.
        • Russell T.A.
        • Otoole J.
        • et al.
        Standardized method for quantification of developing lymphedema in patients treated for breast cancer.
        Int J Radiat Oncol Biol Phys. 2011; 79: 1436-1443
        • Specht M.C.
        • Miller C.L.
        • Russell T.A.
        • et al.
        Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?.
        Breast Cancer Res Treat. 2013; 140: 485-494
        • Stout Gergich N.L.
        • Pfalzer L.A.
        • McGarvey C.
        • et al.
        Preoperative assessment enables the early diagnosis and successful treatment of lymphedema.
        Cancer. 2008; 112: 2809-2819
      1. The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the international society of lymphology.
        Lymphology. 2020; 53: 3-19
        • Davies C.
        • Levenhagen K.
        • Ryans K.
        • et al.
        Interventions for breast cancer-related lymphedema: clinical practice guideline from the academy of oncologic physical therapy of APTA.
        Phys Ther. 2020; 100: 1163-1179
        • McDuff S.G.R.
        • Mina A.I.
        • Brunelle C.L.
        • et al.
        Timing of lymphedema after treatment for breast cancer: when are patients most at risk?.
        Int J Radiat Oncol Biol Phys. 2019; 103: 62-70
        • Földi M.
        • Földi E.
        • S C.
        • et al.
        Földi’s textbook of lymphology. For physicians and lymphedema therapists.
        3rd edition. Urban & Fischer, Amsterdam, Netherlands2012
        • Földi E.
        • Földi M.
        • Stanley R.
        Chapter 31: complete decongestive physiotherapy.
        Lymphedema Springer International Publishing AG, London, UK2018
        • Campbell K.L.
        • Winters-Stone K.
        • Wiskemann J.
        • et al.
        Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable.
        Med Sci Sports Exerc. 2019; 51: 2375-2390
        • Schmitz K.H.
        • Ahmed R.L.
        • Troxel A.B.
        • et al.
        Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial.
        Jama. 2010; 304: 2699-2705
        • Dayes I.S.
        • Whelan T.J.
        • Julian J.A.
        • et al.
        Randomized trial of decongestive lymphatic therapy for the treatment of lymphedema in women with breast cancer.
        J Clin Oncol. 2013; 31: 3758-3763
        • Gradalski T.
        • Ochalek K.
        • Kurpiewska J.
        Complex decongestive lymphatic therapy with or without vodder ii manual lymph drainage in more severe chronic postmastectomy upper limb lymphedema: a randomized noninferiority prospective study.
        J Pain Symptom Manage. 2015; 50: 750-757
        • Smoot B.
        • Chiavola-Larson L.
        • Lee J.
        • et al.
        Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis.
        J Cancer Surviv. 2015; 9: 287-304
        • Marchica P.
        • D’ARPA S.
        • Magno S.
        • et al.
        Integrated treatment of breast cancer-related lymphedema: a descriptive review of the state of the art.
        Anticancer Res. 2021; 41: 3233-3246
        • DiSipio T.
        • Rye S.
        • Newman B.
        • et al.
        Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.
        Lancet Oncol. 2013; 14: 500-515
        • Liu H.L.
        • Pang S.Y.
        • Chan Y.W.
        The use of a microscope with near-infrared imaging function in indocyanine green lymphography and lymphaticovenous anastomosis.
        J Plast Reconstr Aesthet Surg. 2014; 67: 231-236
        • Yamamoto T.
        • Narushima M.
        • Doi K.
        • et al.
        Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns.
        Plast Reconstr Surg. 2011; 128: 941-947
        • Han C.
        • Yang B.
        • Zuo W.S.
        • et al.
        The feasibility and oncological safety of axillary reverse mapping in patients with breast cancer: a systematic review and meta-analysis of prospective studies.
        PLoS One. 2016; 11: e0150285
        • Garza 3rd, R.
        • Skoracki R.
        • Hock K.
        • et al.
        A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies.
        BMC Cancer. 2017; 17: 468
        • Chang D.W.
        • Suami H.
        • Skoracki R.
        A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.
        Plast Reconstr Surg. 2013; 132: 1305-1314
        • Patel K.M.
        • Lin C.Y.
        • Cheng M.H.
        From theory to evidence: long-term evaluation of the mechanism of action and flap integration of distal vascularized lymph node transfers.
        J Reconstr Microsurg. 2015; 31: 26-30
        • Rannikko E.H.
        • Suominen S.H.
        • Saarikko A.M.
        • et al.
        Long-term results of microvascular lymph node transfer: correlation of preoperative factors and operation outcome.
        Plast Reconstr Surg Glob Open. 2021; 9: e3354
        • Dayan J.H.
        • Dayan E.
        • Smith M.L.
        Reverse lymphatic mapping: a new technique for maximizing safety in vascularized lymph node transfer.
        Plast Reconstr Surg. 2015; 135: 277-285
        • Chu C.K.
        • Schaverien M.V.
        • Chang E.I.
        • et al.
        Intra-abdominal Lymph nodes: a privileged donor site for vascularized lymph node transfer.
        Plast Reconstr Surg Glob Open. 2020; 8: e2673
        • Coriddi M.
        • Wee C.
        • Meyerson J.
        • et al.
        Vascularized jejunal mesenteric lymph node transfer: a novel surgical treatment for extremity lymphedema.
        J Am Coll Surg. 2017; 225: 650-657
        • Brorson H.
        Liposuction in lymphedema treatment.
        J Reconstr Microsurg. 2016; 32: 56-65
        • Ozmen T.
        • Lazaro M.
        • Zhou Y.
        • et al.
        Evaluation of simplified lymphatic microsurgical preventing healing approach (S-LYMPHA) for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection.
        Ann Surg. 2019; 270: 1156-1160
        • Abbaci M.
        • Conversano A.
        • De Leeuw F.
        • et al.
        Near-infrared fluorescence imaging for the prevention and management of breast cancer-related lymphedema: A systematic review.
        Eur J Surg Oncol. 2019; 45: 1778-1786
        • Park K.E.
        • Allam O.
        • Chandler L.
        • et al.
        Surgical management of lymphedema: a review of current literature.
        Gland Surg. 2020; 9: 503-511
        • Jørgensen M.G.
        • Toyserkani N.M.
        • Sørensen J.A.
        The effect of prophylactic lymphovenous anastomosis and shunts for preventing cancer-related lymphedema: a systematic review and meta-analysis.
        Microsurgery. 2018; 38: 576-585